Back

Aspirin in the primary prevention of cardiovascular disease in individuals with chronic kidney disease: a systematic review and meta-analysis

17 April 2021 (08:50 - 08:57)
Organised by:
Congress Presentation Part of: Young Investigators Award Primary Care and Risk Factor Management Antiplatelet Drugs EAPC Premium Access ESC Preventive Cardiology 2021

About the speaker

Photo
Doctor Susil Pallikadavath

NIHR Biomedical Research Unit in Cardiovascular Disease, Leicester (United Kingdom of Great Britain & Northern Ireland)

5 More presentations in this session

Presentation thumbnail
Impact of obesity on the clinical outcomes of patients undergoing pacemaker insertion during hospitalization: An analysis of the United States National Inpatient Sample
Doctor M. Almani (Philadelphia, US)
Abstract Slides Video
Presentation thumbnail
Cardiovascular outcomes of ferric carboxymaltose supplementation for the management of iron-deficient acute and chronic heart failure- a meta analysis
Ms A. Abdul Razzack (Hyderabad, IN)
Abstract Slides Video
Presentation thumbnail
Ttrimetyllysine and risk of new-onset atrial fibrillation in two large norwegian cohorts
Doctor M. Svenningsson (Bergen, NO)
Abstract Slides Video
Presentation thumbnail
Province-specific recalibration of CVD risk models using population-specific routine data for Chinese people is important
Ms D. Zhang (Cambridge, GB)
Abstract Slides Video
Presentation thumbnail
Galectin-3 is inversely associated with cardiorespiratory fitness in the general population
Miss M. Haid (Greifswald, DE)
Abstract Slides Video

Access the full session

Session thumbnail
Young Investigators Award Primary Care and Risk Factor Management
Video

The Event

Event poster

ESC Preventive Cardiology 2021

17 April 2021 08:50 CET
You may be interested in
thumbnail
Webinar
Aspirin treatment for mitigating thrombotic risk across the cardiovascular risk continuum
thumbnail
Congress Presentation
Antithrombotic therapy in diabetes
thumbnail
Congress Session
State-of-the-art antithrombotic treatment in acute coronary syndromes: a paradigm shift?

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources